How I treat hypereosinophilic syndromes (Q59291504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

How I treat hypereosinophilic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Amy D Klion

series ordinal

1

0 references

language of work or name

English

0 references

publication date

19 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

3736-3741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome

5 February 2020

cites work

1 reference

12 December 2020

Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia.

1 reference

12 December 2020

Clinical and Immunological Features of Patients with Interleukin-5-Producing T Cell Clones and Eosinophilia

1 reference

12 December 2020

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

1 reference

12 December 2020

Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders

1 reference

12 December 2020

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

1 reference

12 December 2020

Imatinib for systemic mast-cell disease

1 reference

12 December 2020

Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes.

1 reference

12 December 2020

Use of an Anti–Interleukin-5 Antibody in the Hypereosinophilic Syndrome with Eosinophilic Dermatitis

1 reference

12 December 2020

Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome

1 reference

12 December 2020

Familial eosinophilia: a benign disorder?

1 reference

12 December 2020

The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature

1 reference

12 December 2020

Endomyocardial disease and eosinophilia. Report of a case

1 reference

12 December 2020

Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations

1 reference

12 December 2020

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome

1 reference

12 December 2020

Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic Eosinophilia

1 reference

12 December 2020

Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report

1 reference

12 December 2020

Imatinib-responsive hypereosinophilia in a patient with B cell ALL.

1 reference

12 December 2020

Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome.

1 reference

12 December 2020

6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome

1 reference

12 December 2020

Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis

1 reference

12 December 2020

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report

1 reference

12 December 2020

Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript

1 reference

12 December 2020

Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant

1 reference

12 December 2020

Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells

1 reference

12 December 2020

Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1-PDGFRalpha-negative hypereosinophilic syndrome

1 reference

12 December 2020

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

12 December 2020

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

1 reference

12 December 2020

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy

1 reference

12 December 2020

Primary resistance to imatinib in Fip1-like 1-platelet-derived growth factor receptor alpha-positive eosinophilic leukemia

1 reference

12 December 2020

KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities

1 reference

12 December 2020

Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing

1 reference

12 December 2020

Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancy

1 reference

12 December 2020

A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients

1 reference

12 December 2020

Treatment of patients with the hypereosinophilic syndrome with mepolizumab

1 reference

12 December 2020

Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctions

1 reference

12 December 2020

Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation status

1 reference

12 December 2020

10.1182/BLOOD-2009-07-143552

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19692700%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

19692700

1 reference